Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for National Healthcare (NHC) over the last 16 years, with Q3 2025 value amounting to -$9.6 million.

  • National Healthcare's Change in Receivables fell 15044.61% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 8581.27%. This contributed to the annual value of $26.4 million for FY2024, which is 20892.63% up from last year.
  • Latest data reveals that National Healthcare reported Change in Receivables of -$9.6 million as of Q3 2025, which was down 15044.61% from $320000.0 recorded in Q2 2025.
  • Over the past 5 years, National Healthcare's Change in Receivables peaked at $19.1 million during Q3 2024, and registered a low of -$16.3 million during Q2 2024.
  • In the last 5 years, National Healthcare's Change in Receivables had a median value of $1.2 million in 2021 and averaged $1.7 million.
  • Within the past 5 years, the most significant YoY rise in National Healthcare's Change in Receivables was 131891.29% (2024), while the steepest drop was 76856.99% (2024).
  • Over the past 5 years, National Healthcare's Change in Receivables (Quarter) stood at -$2.9 million in 2021, then soared by 133.96% to $983000.0 in 2022, then soared by 504.48% to $5.9 million in 2023, then grew by 10.11% to $6.5 million in 2024, then plummeted by 246.92% to -$9.6 million in 2025.
  • Its Change in Receivables stands at -$9.6 million for Q3 2025, versus $320000.0 for Q2 2025 and $6.4 million for Q1 2025.